These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 32209869)
21. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2. Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791 [No Abstract] [Full Text] [Related]
22. Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma. Badi YE; Pavel AB; Pavlidis S; Riley JH; Bates S; Kermani NZ; Knowles R; Kolmert J; Wheelock CE; Worsley S; Uddin M; Alving K; Bakke PS; Behndig A; Caruso M; Chanez P; Fleming LJ; Fowler SJ; Frey U; Howarth P; Horváth I; Krug N; Maitland-van der Zee AH; Montuschi P; Roberts G; Sanak M; Shaw DE; Singer F; Sterk PJ; Djukanovic R; Dahlen SE; Guo YK; Chung KF; Guttman-Yassky E; Adcock IM; J Allergy Clin Immunol; 2022 Jan; 149(1):89-101. PubMed ID: 33891981 [TBL] [Abstract][Full Text] [Related]
23. New and developing therapies for atopic dermatitis. Hajar T; Gontijo JRV; Hanifin JM An Bras Dermatol; 2018; 93(1):104-107. PubMed ID: 29641707 [TBL] [Abstract][Full Text] [Related]
24. [Analysis of a case series of adult patients with severe atopic dermatitis treated with dupilumab in Argentina]. Máspero J; Angles MV; Ardusso L; Brancciforte M; Castro C; Cruz Iturrieta C; Chouela E; De Gennaro MS; Fernández Bussy R; Galimberti ML; Galimberti RL; Gattolin G; Luna PC; Magariños G; Marini MG; Maskin M; Plafnik R; Raimondo N; Russo JP; Sevinsky L; Stringa MF Rev Fac Cien Med Univ Nac Cordoba; 2020 Jun; 77(2):94-99. PubMed ID: 32558511 [TBL] [Abstract][Full Text] [Related]
25. Dupilumab in atopic dermatitis, a protocol for SARS-COV-2-infected patients. Ordóñez-Rubiano MF; Campo I; Casas M Dermatol Ther; 2020 Nov; 33(6):e14172. PubMed ID: 32779378 [No Abstract] [Full Text] [Related]
26. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records. Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499 [TBL] [Abstract][Full Text] [Related]
27. Restoration of sweating disturbance in atopic dermatitis treated with dupilumab. Mizukawa Y; Sato Y; Ohyama M; Shiohara T J Dermatol Sci; 2020 Oct; 100(1):79-81. PubMed ID: 32900571 [No Abstract] [Full Text] [Related]
28. Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series. Amoedo P; Rosa G; Baudrier T; Pedrosa AF; Cruz MJ An Bras Dermatol; 2024; 99(5):721-724. PubMed ID: 38834396 [No Abstract] [Full Text] [Related]
29. Concurrent therapy with dupilumab and infliximab for atopic dermatitis and Crohn's disease. Pires DA Rosa G; Cruz MJ; Azevedo F; Mota A Ital J Dermatol Venerol; 2024 Aug; 159(4):473-474. PubMed ID: 38804086 [No Abstract] [Full Text] [Related]
30. Dupilumab for treatment of severe atopic dermatitis in a heart transplant recipient. Hamid RN; Bomar L; Strowd L Cutis; 2019 Jun; 103(6):E1-E2. PubMed ID: 31348459 [No Abstract] [Full Text] [Related]
31. Ustekinumab in the treatment of severe atopic dermatitis: a preliminary report of our experience with 4 patients. Fernández-Antón Martínez MC; Alfageme Roldán F; Ciudad Blanco C; Suárez Fernández R Actas Dermosifiliogr; 2014 Apr; 105(3):312-3. PubMed ID: 24657022 [No Abstract] [Full Text] [Related]
32. Atopic dermatitis is an important comorbidity in severe asthma. Lee JK; Han D Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463 [No Abstract] [Full Text] [Related]
33. Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials. Blauvelt A; Rosmarin D; Bieber T; Simpson EL; Bagel J; Worm M; Deleuran M; Katoh N; Kawashima M; Shumel B; Chen Z; Rossi AB; Hultsch T; Ardeleanu M Br J Dermatol; 2019 Jul; 181(1):196-197. PubMed ID: 30719707 [No Abstract] [Full Text] [Related]
34. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series. Armario-Hita JC; Pereyra-Rodriguez J; Silvestre JF; Ruiz-Villaverde R; Valero A; Izu-Belloso R; Jáuregui-Presa I; Curto-Barredo L; Figueras-Nart I; Herranz-Pinto P; Herraez-Herrera L; Ortiz-de-Frutos FJ; Martinez-Pilar L; Sastre J; Serra-Baldrich E Br J Dermatol; 2019 Nov; 181(5):1072-1074. PubMed ID: 31021399 [No Abstract] [Full Text] [Related]
35. Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome. Murase C; Takeichi T; Taki T; Yoshikawa T; Suzuki A; Ogi T; Suga Y; Akiyama M J Dermatol Sci; 2021 May; 102(2):126-129. PubMed ID: 33773888 [No Abstract] [Full Text] [Related]
36. Long-term treatment of severe recalcitrant atopic dermatitis with omalizumab, an anti-immuno-globulin E. Quist SR; Ambach A; Göppner D; Quist J; Franke I; Bonnekoh B; Gollnick HP Acta Derm Venereol; 2013 Mar; 93(2):206-8. PubMed ID: 23042516 [No Abstract] [Full Text] [Related]
37. Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS. Silverberg JI; Yosipovitch G; Simpson EL; Kim BS; Wu JJ; Eckert L; Guillemin I; Chen Z; Ardeleanu M; Bansal A; Kaur M; Rossi AB; Graham NMH; Patel N; Gadkari A J Am Acad Dermatol; 2020 Jun; 82(6):1328-1336. PubMed ID: 32135208 [TBL] [Abstract][Full Text] [Related]
38. Strategies for Successful Management of Severe Atopic Dermatitis. Brar KK; Nicol NH; Boguniewicz M J Allergy Clin Immunol Pract; 2019 Jan; 7(1):1-16. PubMed ID: 30598172 [TBL] [Abstract][Full Text] [Related]
39. Successful preoperative intervention of dupilumab in high-risk surgery in a patient with severe atopic dermatitis. Goto H; Moriki M; Sano Y; Yagi H; Tokura Y J Dermatol; 2020 Feb; 47(2):e50-e51. PubMed ID: 31823419 [No Abstract] [Full Text] [Related]